Speech-language pathology manifestations reported by parents of children with congenital hypothyroidism

L. Ferreira, Ranielly da Costa Relvas, Márcia Suely Souza de Castro Ramalho, C. Ronchi, Viviane Castro de Araújo Perillo, Lidiane Cristina Barravieira Rodrigues
{"title":"Speech-language pathology manifestations reported by parents of children with congenital hypothyroidism","authors":"L. Ferreira, Ranielly da Costa Relvas, Márcia Suely Souza de Castro Ramalho, C. Ronchi, Viviane Castro de Araújo Perillo, Lidiane Cristina Barravieira Rodrigues","doi":"10.1590/S1516-80342011000300013","DOIUrl":null,"url":null,"abstract":"Purpose: To identify speech-language pathology manifestations presented by children with congenital hypothyroidism, and to investigate the association of such manifestations with the time of diagnosis and beginning of treatment. Methods: Caregivers of 15 children diagnosed with congenital hypothyroidism who attended the Reference Service on Neonatal Screening of the states of Rondônia and Acre answered a questionnaire in which they should report mainly speech-language pathology complaints. Children’s age ranged from 2 to 7 years, 67% of boys and 33% of girls. The average age at the time of diagnosis was 1 month and 3 days, and treatment started, in average, at 1 month and 6 days. The dosage of the drug varied from 5 mg/day to 100 mg/day. Results: The complaints reported were: delay in the onset of oral language, speech alterations, unintelligible speech, agitated and nervous behavior. Some caregivers did not report any complaints. It was found that most subjects had problems with speech (80%), and a few had hearing impairment (7.7%). For those who reported complaints, mean time of diagnosis and beginning of treatment was delayed when compared to those who did not report. Conclusion: Speech-language pathology manifestations were reported, especially regarding speech. Moreover, there was association between the presence of complaints and speech disorders with the time of diagnosis and beginning of treatment. It is suggested the inclusion of the speech-language pathologist and audiologist in the team monitoring the development of children with congenital hypothyroidism.","PeriodicalId":21204,"journal":{"name":"Revista Da Sociedade Brasileira De Fonoaudiologia","volume":"20 1","pages":"317-322"},"PeriodicalIF":0.0000,"publicationDate":"2011-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1590/S1516-80342011000300013","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista Da Sociedade Brasileira De Fonoaudiologia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1590/S1516-80342011000300013","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Purpose: To identify speech-language pathology manifestations presented by children with congenital hypothyroidism, and to investigate the association of such manifestations with the time of diagnosis and beginning of treatment. Methods: Caregivers of 15 children diagnosed with congenital hypothyroidism who attended the Reference Service on Neonatal Screening of the states of Rondônia and Acre answered a questionnaire in which they should report mainly speech-language pathology complaints. Children’s age ranged from 2 to 7 years, 67% of boys and 33% of girls. The average age at the time of diagnosis was 1 month and 3 days, and treatment started, in average, at 1 month and 6 days. The dosage of the drug varied from 5 mg/day to 100 mg/day. Results: The complaints reported were: delay in the onset of oral language, speech alterations, unintelligible speech, agitated and nervous behavior. Some caregivers did not report any complaints. It was found that most subjects had problems with speech (80%), and a few had hearing impairment (7.7%). For those who reported complaints, mean time of diagnosis and beginning of treatment was delayed when compared to those who did not report. Conclusion: Speech-language pathology manifestations were reported, especially regarding speech. Moreover, there was association between the presence of complaints and speech disorders with the time of diagnosis and beginning of treatment. It is suggested the inclusion of the speech-language pathologist and audiologist in the team monitoring the development of children with congenital hypothyroidism.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
先天性甲状腺功能减退症患儿家长报告的语言病理表现
目的:探讨先天性甲状腺功能减退症患儿的语言病理表现,并探讨其与诊断时间和治疗开始时间的关系。方法:15例先天性甲状腺功能减退儿童的护理人员参加Rondônia和Acre州新生儿筛查参考服务,填写问卷,主要报告语言病理投诉。儿童的年龄从2岁到7岁不等,67%的男孩和33%的女孩。确诊时的平均年龄为1个月零3天,开始治疗的平均年龄为1个月零6天。药物的剂量从每天5毫克到每天100毫克不等。结果:报告的主诉为:口语发作延迟、言语改变、言语不清、激动和神经行为。一些护理人员没有报告任何投诉。结果发现,大多数受试者有语言障碍(80%),少数有听力障碍(7.7%)。与未报告的患者相比,报告患者的平均诊断和开始治疗时间延迟。结论:报告了言语语言病理表现,特别是在言语方面。此外,出现的抱怨和语言障碍与诊断时间和治疗开始之间存在关联。建议将语言病理学家和听力学家纳入监测先天性甲状腺功能减退症患儿发展的小组。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
审稿时长
36 weeks
期刊最新文献
Comparação dos estímulos clique e CE-chirp® no registro do Potencial Evocado Auditivo de Tronco Encefálico Tipos de erros de fala em crianças com transtorno fonológico em função do histórico de otite média Ocorrência de dessonorização no desvio fonológico: relação com fonemas mais acometidos, gravidade do desvio e idade Grau de quantidade de fala e intensidade vocal de teleoperadores em ambiente laboral e extralaboral A efetividade dos testes complementares no acompanhamento da intervenção terapêutica no transtorno fonológico
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1